Literature DB >> 25126248

Switching to generic antiepileptic drugs: growing concerns.

Dalia Buffery.   

Abstract

Year:  2008        PMID： 25126248      PMCID： PMC4106570     

Source DB:  PubMed          Journal:  Am Health Drug Benefits        ISSN： 1942-2962


× No keyword cloud information.
  5 in total

1.  Generic substitution in the treatment of epilepsy: patient and physician perceptions.

Authors:  Michel J Berg; Robert A Gross; Lisa S Haskins; Wendy M Zingaro; Kenneth J Tomaszewski
Journal:  Epilepsy Behav       Date:  2008-09-10       Impact factor: 2.937

2.  Generic substitution in the treatment of epilepsy: case evidence of breakthrough seizures.

Authors:  M J Berg; R A Gross; K J Tomaszewski; W M Zingaro; L S Haskins
Journal:  Neurology       Date:  2008-08-12       Impact factor: 9.910

3.  Generic antiepileptic drugs.

Authors:  Susan J Shaw; Gregory L Krauss
Journal:  Curr Treat Options Neurol       Date:  2008-07       Impact factor: 3.598

4.  Clinical consequences of generic substitution of lamotrigine for patients with epilepsy.

Authors:  J LeLorier; M S Duh; P E Paradis; P Lefebvre; J Weiner; R Manjunath; O Sheehy
Journal:  Neurology       Date:  2008-05-27       Impact factor: 9.910

5.  Economic impact of generic substitution of lamotrigine: projected costs in the US using findings in a Canadian setting.

Authors:  Jacques LeLorier; Mei Sheng Duh; Pierre Emmanuel Paradis; Dominick Latrémouille-Viau; Patrick Lefebvre; Ranjani Manjunath; Odile Sheehy
Journal:  Curr Med Res Opin       Date:  2008-02-29       Impact factor: 2.580
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.